PFIZER

Moderna’s CEO is defending a plan to more than quadruple the company’s COVID-19 vaccine price.

U.S. health regulators voted in favor of a full approval for Pfizer's COVID pill Paxlovid. This pill will will help adults who are at high risk of progression to severe virus.

U.S. health advisersare backing the continued use of Pfizer’s COVID-19 pill Paxlovid, saying it remains an important option for adults at high risk of severe illness.

The Fox News Health Newsletter brings you trending and important stories about health warnings, drug shortages, mental health issues and more in this weekly recap.

The FDA has approved Pfizer's nasal spray to treat migraines in adults. The medication, called Zavzpret, is expected to be available via a doctor's prescription in July 2023.

Drugmaker plans to roll out the drug, which it says can relieve migraine symptoms in 30 minutes, to pharmacies in July.

A majority of the FDA panel said GSK's vaccine safety data was adequate, and the advisors were unanimous that the shot's efficacy was good.

Federal health advisers have narrowly backed an experimental vaccine from Pfizer that could become the first shot to protect older adults against the respiratory illness known as RSV.

The vote followed concerns at the FDA and among advisory committee members about two cases of Guillain-Barre syndrome among about 20,000 vaccine recipients. The FDA has asked Pfizer to conduct a safety study on Guillain-Barre syndrome, which the company has agreed to do. There currently is no approved RSV vaccine for the elderly. Pfizer's vaccine contains both strains of RSV, which circulate at the same time during fall and winter. Dr. David Kaslow, a senior official in the FDA's vaccine division, said safety monitoring will be "critically important" if Pfizer's RSV vaccine is approved.

The FDA sees a potential risk and has asked Pfizer to conduct a safety study on Guillain-Barre after a potential approval, which the company said it would do.

The single-dose RSV vaccine developed by Pfizer is administered to expectant mothers in the late second-to-third trimester of their pregnancy.

For those who wish to receive a COVID-19 vaccine, now is your chance. The Edinburg Chamber of Commerce is partnering with DHR Health to host a vaccination clinic Thursday, Feb. 23 from 9 a.m. to 4 p.m. for the clinic, which will be held at the Edinburg Chamber located at 602 W. University Drive. Pfizer and Moderna Bivalent COVID-19 vaccines will be available to everyone including children over 6 months old. Those who wish to receive a booster must have proof of a prior COVID-19 vaccination and must have a two-month span from the previous dose. For more information one can call (956) 362-6843.

The company announced a patient assistance program as it prepares for government-bought supplies to run out.

Insurers, employers, taxpayers and other consumers will all be affected as drugmakers move these products to the commercial market in May. How much you'll pay depends on your health insurance.

Under the Affordable Care Act, most Americans would still get their Covid shots for free once the vaccine program goes commercial.

California won’t make children get the coronavirus vaccine to attend schools.

None of these are legit, even though they were shared widely on social media. CLAIM: House Republicans are requiring Rep. Jamie Raskin, a Democrat from Maryland, to remove the headwear he’s donned on the House floor while undergoing chemotherapy. THE FACTS: Republicans have made no such request and have in fact been nothing but supportive, a spokesperson for Raskin told the AP.

DC Studios co-head James Gunn defended "Shazam" star Zachery Levi after the actor prompted a backlash for criticizing COVID-19 vaccine manufacturer Pfizer.

Sales of Paxlovid surged to $18.9 billion in 2022 which was the first full-year that the antiviral pill was available.

The pharmaceutical company booked $100.3 billion for full-year 2022, an all-time high.

Fox News host Tucker Carlson exposes Pfizer's alleged manipulation of the COVID-19 virus as many suffer from the pandemic on "Tucker Carlson Tonight."

The Food and Drug Administration's independent advisory committee on Thursday unanimously recommended replacing Pfizer and Moderna's original Covid vaccine used in the U.S. for everyone's first two immunizations with the new bivalent omicron shots. Instead, the drugmakers' bivalent omicron shots that target the omicron BA.5 subvariant as well as the original strain would be used for the entire vaccination series. Currently, Pfizer's and Moderna's omicron shots are only authorized as a booster, while the first two doses are still their old shots based on the original Covid strain. The FDA has proposed moving to a system that resembles how the agency updates and rolls out flu shots every year. The agency would select a Covid vaccine formulation in June to target the variant that is expected to dominate in the fall and winter.

Preliminary CDC data indicated a possible stroke risk following simultaneous administration of the Pfizer Covid booster and the flu vaccine.

These are the stocks posting the largest moves in premarket trading.

The CDC study published Wednesday provides the first estimate of the omicron shots' real-world effectiveness against the XBB family of subvariants. For people ages 18 to 49, the omicron booster reduced the risk of mild illness by about 48% two to three months after receiving the shot. The shots provided 38% protection against mild illness for those ages 50 to 64 and 42% protection for people ages 65 and older, according to the study. They had very little protection against mild illness due to waning immunity observed with the old vaccines, Link-Gelles said. It's too early to draw conclusions about how the protection from the omicron boosters holds up over time, she said.

These are the stocks posting the largest moves premarket.

The CDC said one of its monitoring systems detected a preliminary safety signal for stroke in people ages 65 and older who received the Pfizer omicron booster.

The agencies said the surveillance signal “is very unlikely” to represent a “true clinical risk” and said they continued to recommend the vaccine.

The CDC has identified a "safety signal" in the Bivalent Pfizer-BioNTech and is investigating whether the shot creates an increased stroke risk for people 65 and older.

Twitter owner and CEO Elon Musk waded into a discussion about COVID-19 boosters in a tweet on Wednesday, with the billionaire claiming that it “isn’t clear whether, all things considered, a second booster helps or hurts.”

The Conservative MP has been suspended after a tweet comparing Covid vaccine side effects to the Holocaust.

Alex Berenson was the latest writer to be tapped by Elon Musk to dive into Twitter's archives, showing Dr. Scott Gottlieb, a Pfizer board member, targeting vaccine skepticism.

China will not include Pfizer’s COVID-19 treatment drug in a national reimbursement list that would have allowed patients to get it at a cheaper price, saying it was too expensive.

The company aims to test 10,000 personalized mRNA therapies, including cancer vaccines, between September 2023 to the end of the decade.

But Chinese tourists will not have unfettered access to all countries - as some impose restrictions.

Germany has dispatched a batch of the BioNTech-Pfizer COVID-19 vaccine to China, where it will be administered to Germans who live in the country

Robert Malone, an mRNA vaccine researcher, has returned to Twitter after being banned from the platform over its coronavirus misinformation policy.

In a press release Pfizer says its maternal shot was 69% effective in preventing severe RSV infection in infants 0-6 months.

The decision aims to better protect the littlest kids amid an uptick in COVID-19 cases around the country. The Centers for Disease Control and Prevention is expected to sign off soon.

The FDA on Thursday approved the use of updated COVID-19 vaccines for children younger than 5, three days after Pfizer-BioNTech applied for an emergency use authorization.

U.S. regulators have cleared doses of the updated COVID-19 vaccines to children younger than 5.

The FDA's decision to authorize the shots for the youngest kids comes as Covid infections and hospitalizations are increasing nationally.

Pfizer said the FDA has accepted its RSV vaccine candidate for review under an expedited process that reduces the approval process by four months.

The boosters did not trigger a robust response against BQ.1.1. People with a prior history of infection who received the booster had a stronger response

Pfizer is asking U.S.[San Marcos, TX] [Hays County news] News San Marcos News, San Marcos Record [Texas State]

Pfizer is asking U.S. regulators to authorize its updated COVID-19 vaccine for children under age 5.

The study did not look at hospitalization, but experts believe the omicron booster shots will provide strong protection against severe outcomes.

The BQ coronavirus subvariants are likely resistant to key antibody medications used by people with compromised immune systems.

Pfizer said the booster triggered more antibodies against omicron BQ.1.1, BA.4.6, BA.2.75.2 and XBB.1 in adults older than 55 compared to the original vaccines.

The Indian Health Service says all tribal members covered by the federal agency will be offered a vaccine at every appointment, when appropriate.

A study published in Lancet Respiratory Medicine found that 1.8% of healthy infants are hospitalized with RSV before their first birthday.

A study of health records for 60,000 patients suggests the treatment might be useful in preventing long Covid, but the conclusion is far from certain.

People older than 55 who received the new Covid booster had about four times more antibodies targeting omicron BA.5 than people who received the old vaccine.

CEO Albert Bourla said Pfizer is staring down an expected loss of up to $18 billion in revenue from 2025 through 2030 as patent protections expire.

These are the stocks posting the largest moves in midday trading Tuesday, Nov. 1.

Pfizer now expects earnings per share of $6.40 to $6.50 for the year, up from its previous forecast of $6.30 to $6.45.

Pfizer said it will submit an application to the Food and Drug Administration for the RSV vaccine's approval by the end of 2022.

Stocks gave up early gains and ended lower on Wall Street after an unexpectedly strong report on the job market raised concerns that the Federal Reserve will need to keep the pressure on inflation with aggressive interest rate increases.

After decades of researching respiratory syncytial virus, scientists announced a major development for a possible vaccine that could be available as soon as next year

Pfizer will charge $110 to $130 for a dose of its COVID-19 vaccine once the U.S. government stops buying the shots.

A state audit says the North Dakota Health Department stored thousands of COVID-19 vaccine doses at incorrect temperatures or without temperature data over the past two years — and that some of the vaccine was administered to patients.

The U.S. is about to offer updated COVID-19 booster shots to kids as young as 5.

Pfizer is asking the Food and Drug Administration to expand use of its updated COVID-19 booster shot to children ages 5 to 11.

Israel has started administering doses of the new COVID-19 vaccine tailored to fight the highly infectious omicron variant.

The European Medicines Agency has recommended the authorization of a tweaked booster dose of the Pfizer-BioNTech coronavirus vaccine that includes protection against two of the latest versions of omicron, as countries look to bolster their immunization programs ahead of winter.

University Health will begin offering the Pfizer-BioNTech bivalent COVID-19 vaccine starting Tuesday to provide a new layer of protection against the Omicron variant.

New COVID-19 boosters targeting today’s most common omicron strains should begin arriving within days.

Updated COVID-19 booster shots are expected to roll out soon, which is why the San Antonio Metropolitan Health District is no longer offering the original boosters to anyone 12 years old or older.

New COVID-19 boosters that target today's most common omicron strains are set to begin soon.

The European Medicines Agency has recommended the authorization of two coronavirus vaccines made by Pfizer-BioNTech and Moderna Inc., tweaked to include protection against an early version of the omicron variant.

The Biden administration hopes to make getting a COVID-19 booster as routine as going in for the yearly flu shot.

California won't allow teens age 15 and up to be vaccinated against the coronavirus without their parents' consent.

U.S. regulators have authorized updated COVID-19 boosters, the first to directly target today's most common omicron strain.

Pharmaceuticals Pfizer and BioNTech say they have asked the European Medicines Agency to authorize their updated coronavirus booster vaccine that includes the most recent omicron subvariants.

COVID-19 vaccines tweaked to better match today’s omicron threat are expected to roll out in a few weeks but how much will they help.

Pfizer’s COVID-19 pill appears to provide little or no benefit for younger adults.

University Health director of hospital epidemiology Dr. Jason Bowling answers some of the most frequently asked questions about COVID-19, boosters, new vaccines and new CDC recommendations.

Pfizer’s says its COVID-19 vaccine was 73% effective in protecting children younger than 5 as omicron spread in the spring.

Pfizer has asked U.S. regulators to authorize its combination COVID-19 vaccine that adds protection against the newest omicron relatives.

Researchers are seeking thousands of volunteers in the U.S. and Europe to test the first potential vaccine against Lyme disease in 20 years.

BioNTech, which teamed with Pfizer to develop a powerful COVID-19 vaccine, has reported higher revenue and net profit in the first half of the year.

U.S. regulators say they are no longer considering authorizing second COVID-19 booster shots for all adults under 50 this summer.

Everyone in Britain who is 50 or over will be offered a fourth dose of coronavirus vaccine in the fall, lowering the age threshold from the previously announced 65.

The U.S. is getting another COVID-19 vaccine choice.

For some parents of kids under 5 who want to vaccinate them, the wait has been excruciating, fraught with delays and close calls. Others are hesitant to have their young children vaccinated.

U.S. pharmacists can now prescribe the leading COVID-19 pill directly to patients.

U.S. regulators are telling COVID-19 vaccine makers to tweak any booster doses intended for fall so they protect against the newest omicron relatives.

Government advisers are recommending that some U.S. adults get a modified COVID-19 booster shot this fall — one that better matches more recent virus variants.

U.S. health authorities are facing a critical decision: whether to offer new COVID-19 booster shots this fall that are modified to better match the latest changes of the shape-shifting coronavirus.

Pfizer says tweaking its COVID-19 vaccine to better target the omicron variant is safe and boosts protection.

Scientists estimate that nearly 20 million lives were saved worldwide by COVID-19 vaccines during their first year.

An expert panel backed a second COVID-19 vaccine option for kids ages 6 to 17.

San Antonio Metro Health announced Tuesday it will offer the COVID-19 vaccine to children, ages 6 months older.

U.S. health officials have opened COVID-19 vaccines for infants, toddlers and preschoolers — the last group without the shots.

U.S. regulators have authorized the first COVID-19 shots for infants and preschoolers.

COVID-19 shots for infants, toddlers and preschoolers in the U.S. have moved a step closer.

A government advisory panel has endorsed a second brand of COVID-19 vaccine for school-age children and teens.

A review by federal health officials says that Pfizer's COVID-19 vaccine appears safe and effective for children under 5, the only group not currently eligible for vaccination.

Next week brings a marathon of hearings as the U.S. decides whether to open COVID-19 vaccinations to kids under 5.

White House officials say orders have been coming in for COVID-19 vaccine doses for small children.